Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2 clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's disease. Cassava Sciences, Inc. was formerly known as Pain Therapeutics, Inc. and changed its name to Cassava Sciences, Inc. in March 2019. The company w...
Oct 22, 2025, 4:05 PM EDT - 6 weeks ago
Oct 22, 2025, 8:00 AM EDT - 6 weeks ago
Aug 14, 2025, 7:30 AM EDT - 4 months ago
Aug 7, 2025, 7:30 AM EDT - 4 months ago
Aug 4, 2025, 7:30 AM EDT - 4 months ago
Jun 30, 2025, 7:00 AM EDT - 5 months ago
May 1, 2025, 7:30 AM EDT - 7 months ago
Apr 21, 2025, 4:30 PM EDT - 8 months ago
Mar 26, 2025, 3:49 PM EDT - 9 months ago
Mar 25, 2025, 10:42 AM EDT - 9 months ago
Mar 25, 2025, 8:05 AM EDT - 9 months ago
Mar 3, 2025, 7:30 AM EST - 9 months ago
Feb 9, 2025, 10:45 AM EST - 10 months ago
Feb 7, 2025, 12:08 PM EST - 10 months ago
Feb 3, 2025, 5:45 AM EST - 10 months ago
Jan 23, 2025, 2:47 PM EST - 11 months ago
Jan 7, 2025, 4:30 PM EST - 11 months ago
Dec 23, 2024, 5:45 AM EST - 1 year ago
Dec 18, 2024, 10:53 AM EST - 1 year ago
Dec 13, 2024, 1:16 PM EST - 1 year ago
Dec 10, 2024, 10:00 AM EST - 1 year ago